Diamonds and Dogs
Moderna (MRNA) higher on an upgrade and news they are getting added to the S&P 500. Moderna is up 8% to new highs as they will be added to the S&P 500 next week. Jefferies analyst upgraded the stock saying the company is the, "Tesla of biotech", however, his price target of $250 has already been surpassed.
Charles Schwab (SCHW) reported mixed results. Schwab is down 3% to a three-month low after missing earnings estimates. Trading revenue decelerate sharply from the first quarter. A sign that the retail trading surge may be winding down. Schwab completed its merger with TD Ameritrade in October, sharply increasing its asset base and client accounts.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.